Company Filing History:
4 out of 4,816 
1 out of 18 Years Active: 2015-2020
Title: Frank Emmrich: Innovator in Immunology
Introduction
Frank Emmrich is a notable inventor based in Leipzig, Germany. He has made significant contributions to the field of immunology, particularly in the development of anti-CD4 antibodies. With a total of five patents to his name, Emmrich's work focuses on preventing graft-versus-host disease (GVHD), a serious complication that can arise after cell transplants.
Latest Patents
One of Emmrich's latest patents involves an innovative in vitro method for modifying a cell graft containing immune cells. This method includes incubating the cell graft with an anti-CD4 antibody for a duration ranging from one minute to seven days. Following this incubation, unbound antibodies are removed from the graft. The invention also addresses the modification of antibodies that react to the CD4 human leukocyte antigen. This modification aims to create anti-CD4 antibodies with fewer potential T-cell epitopes while maintaining their ability to bind to CD4. The specificity and mode of action of these antibodies are preserved despite the modifications.
Career Highlights
Throughout his career, Frank Emmrich has worked with esteemed organizations such as the Fraunhofer Society for the Advancement of Applied Research and the University of Leipzig. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Emmrich has collaborated with notable colleagues, including Stephan Fricke and Nadja Hilger. These partnerships have further enriched his research endeavors and have led to significant advancements in his field.
Conclusion
Frank Emmrich's innovative work in the development of anti-CD4 antibodies showcases his commitment to advancing immunological research. His contributions are vital in the fight against graft-versus-host disease, and his patents reflect his expertise and dedication to improving patient outcomes.